Scinai Immunotherapeutics (SCNI) Gross Margin (2024 - 2026)
Scinai Immunotherapeutics (SCNI) posted Gross Margin of 228.63% for Q1 2026, up 71.46% sequentially from 801.07% in Q2 2025, and down 26754.0% YoY from N/an in Q1 2025.
Scinai Immunotherapeutics (SCNI) Gross Margin (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Gross Margin for 3 years, with the latest figure at 228.63% in Q1 2026.
- Quarterly Gross Margin fell 26754.0% year-over-year to 228.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 174.05% (changed N/A YoY) and the FY2025 annual result came in at 181.41%, down 9327.0% from the prior year.
- Gross Margin grew to 228.63% in Q1 2026 per SCNI's latest filing, from 801.07% in the prior quarter.
- Over five years, Gross Margin peaked at 38.91% in Q1 2025 and troughed at 801.07% in Q2 2025.
- A 3-year average of 244.01% and a median of 148.21% in 2024 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 26754 bps in 2026, down 26754 bps in 2026.
- Over 3 years, Gross Margin stood at 81.07% in 2024, then plunged by 888 bps to 801.07% in 2025, then surged by 71 bps to 228.63% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 228.63%, 801.07%, and 38.91% for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | -228.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228.63% |
| Jun 30, 2025 | -801.07% |
| Mar 31, 2025 | 38.91% |
| Dec 31, 2024 | -81.07% |
| Sep 30, 2024 | -148.21% |